ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,889.52
      0.30%
      US Tech 100
      20,658.80
      0.00%
      Dow Jones
      42,475.40
      0.35%
      Brent Oil
      72.57
      -0.23%
      Bitcoin
      97,468.27
      -2.61%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Abivax (ABVX) Quote

      Abivax

      Abivax (ABVX)

      Abivax SA
      7.50
      0.02
      (0.27%)
      Closed December 19 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      7.50
      Bid
      7.31
      Ask
      7.65
      Volume
      11,956
      7.31 Day's Range 7.53
      6.95 52 Week Range 15.42
      Market Cap
      471.966M
      Previous Close
      7.48
      Open
      7.34
      Last Trade
      51
      @
      7.5
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      22,821
      Shares Outstanding
      62,928,818
      Dividend Yield
      -
      PE Ratio
      -3.19
      Earnings Per Share (EPS)
      -2.35
      Revenue
      4.62M
      Net Profit
      -147.74M

      About Abivax

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.abivax.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Abivax is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABVX. The last closing price for Abivax was 7.48 €. Over the last year, Abivax shares have traded in a share price range of 6.95 € to 15.42 €.

      Abivax currently has 62,928,818 shares outstanding. The market capitalization of Abivax is 470.71 € million. Abivax has a price to earnings ratio (PE ratio) of -3.19.

      Ask ADVFN Intelligence (AI)

      ABVX Latest News

      More News

      Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

      Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

      November 19 2024
      GlobeNewswire Inc.

      Abivax presents third quarter 2024 key financial information

      Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

      November 14 2024
      GlobeNewswire Inc.

      Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

      Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax PARIS, France, November 13, 2024, 10:00 pm CET – Abivax SA (Euronext Paris and...

      November 13 2024
      GlobeNewswire Inc.

      Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation

      Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation PARIS, France, October 7, 2024, 10:00...

      October 07 2024
      GlobeNewswire Inc.

      Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease

      Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris:...

      October 03 2024
      GlobeNewswire Inc.

      Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance

      Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance Patients...

      October 03 2024
      GlobeNewswire Inc.

      Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

      Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024 Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy...

      September 26 2024
      GlobeNewswire Inc.

      Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model

      Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease...

      September 25 2024
      GlobeNewswire Inc.

      Abivax presents first-half 2024 financial results

      Abivax presents first-half 2024 financial results Cash balance of EUR 222M at June 30, 2024; cash runway in to Q4 2025 PARIS, France, September 9, 2024, 10:00 p.m. CEST – Abivax SA (Euronext...

      September 09 2024
      GlobeNewswire Inc.

      Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone

      Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) surpassed the...

      August 06 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.22-2.849740932647.727.766.95207837.28538512DE
      4-0.79-9.529553679138.298.76.95228257.79253664DE
      12-2.7-26.470588235310.210.56.95228218.64545762DE
      26-5.04-40.191387559812.5413.36.95201169.92650575DE
      52-2.44-24.54728370229.9415.426.952544611.36091016DE
      156-18.5-71.153846153826295.63170512.06467569DE
      260-10.06-57.289293849717.56395.63338316.86448018DE

      ABVX - Frequently Asked Questions (FAQ)

      What is the current Abivax share price?
      The current share price of Abivax is 7.50 €
      How many Abivax shares are in issue?
      Abivax has 62,928,818 shares in issue
      What is the market cap of Abivax?
      The market capitalisation of Abivax is EUR 470.71M
      What is the 1 year trading range for Abivax share price?
      Abivax has traded in the range of 6.95 € to 15.42 € during the past year
      What is the PE ratio of Abivax?
      The price to earnings ratio of Abivax is -3.19
      What is the cash to sales ratio of Abivax?
      The cash to sales ratio of Abivax is 102.18
      What is the reporting currency for Abivax?
      Abivax reports financial results in EUR
      What is the latest annual turnover for Abivax?
      The latest annual turnover of Abivax is EUR 4.62M
      What is the latest annual profit for Abivax?
      The latest annual profit of Abivax is EUR -147.74M
      What is the registered address of Abivax?
      The registered address for Abivax is 7-11 BOULEVARD HAUSSMANN, PARIS, PARIS, 75009
      What is the Abivax website address?
      The website address for Abivax is www.abivax.com
      Which industry sector does Abivax operate in?
      Abivax operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLFTIFrance Tourisme Immobilier
      0.039 €
      (95.00%)
      		50k
      MLSMLSmalto
      0.02 €
      (81.82%)
      		11k
      MLWEYWeya
      0.019 €
      (40.74%)
      		58.35k
      ALEUPEuroplasma
      0.042 €
      (32.49%)
      		4.42M
      ALMARMare Nostrum
      0.40 €
      (20.12%)
      		3.31k
      MLAAHAmatheon Agri Holding NV
      0.012 €
      (-40.00%)
      		37.04k
      ALCRBCarbios
      6.09 €
      (-34.16%)
      		552.36k
      ARVBSArverne Group
      0.10 €
      (-33.33%)
      		1.2k
      MLCOTCoretech 5
      0.008 €
      (-20.00%)
      		34k
      MLSUMSumo Resourcs Plc
      0.004 €
      (-20.00%)
      		3.26k
      ATOAtos SE
      0.0021 €
      (0.00%)
      		4.01B
      BCPBanco Comercial Portugues SA
      0.4524 €
      (0.24%)
      		71.38M
      ALHGLouis Hachette Group
      1.2722 €
      (-6.39%)
      		24.46M
      ALVERVergnet
      0.0022 €
      (0.00%)
      		20.13M
      VIVVivendi SE
      2.451 €
      (-5.59%)
      		19.74M

      Discussion

      View Full Feed
      Involuntary-Recluse Involuntary-Recluse 2 minutes ago
      Tell that to Judge Zurn 😂
      CLHI
      Spectra777 Spectra777 3 minutes ago
      Yes I wouldn't expect any official strategic announcement until well into the first quarter post inauguration as a point of reference if not into February. If not, I am at a complete loss lol.
      SEV
      36Knuckle 36Knuckle 3 minutes ago
      SO...OTCChaser!?...you've been around since May and this was your 7th CAVR post...I have not seen anything posted about KevCox to that effect...You might want to add some background or links to who/what you/think you know...we are all concerned about our bags as well you can understand...especially
      CAVR
      Steady_T Steady_T 3 minutes ago
      Interesting article about plasma biomarkers.
      The study found that all tested plasma biomarkers (except for NfL) were associated with accumulation of misfolded amyloid in the brain, highlighting the role of amyloid in the phosphorylation of tau.

      " says Dr. Bluma. "Unlike these
      AVXL
      Involuntary-Recluse Involuntary-Recluse 3 minutes ago
      Actually, they laugh at me for being a dinosaur heterosexual in this day and age. They try to convince me that i am missing out 😂

      I in turn reply, that if missing out makes me continue to fantasize about Halle Berry and myself in a hot tub, i choose to continue being delusiona
      ASKH
      DimesForShares DimesForShares 3 minutes ago
      In addition, the video made the claim that they had doubled the yield over their previous silkworms, not doubling the yield over the best commercial silkworms.

      KBLB tested existing hybrids to find the ones best suited to Vietnam and then incorporated their GMO silk genes into existing
      KBLB
      madcasper madcasper 3 minutes ago
      sounds dishonest, I just get lucky now and again.
      do not have the skills to stack odds on these tickers.. lol
      CGAC
      CGAC
      manibiotech manibiotech 4 minutes ago
      I asked the board here as usual few are lot more knowledgeable than me . 
      Of course I can't ask NWBO as their IR can't answer that question as it has no ownership or control of other company
      NWBO
      Lone Clone Lone Clone 4 minutes ago
      Canadian Critical Minerals Generates USD$198,000 in Revenue from Bull River Mine

      https://www.newsfilecorp.com/release/234324/Canadian-Critical-Minerals-Generates-USD198000-in-Revenue-from-Bull-River-Mine

      December 18, 2024 1:05 PM EST | Source: Canadian Critical Mineral
      lakers17 lakers17 4 minutes ago
      Crypto still getting hammered since that damn FED meeting. BTC at $98,600. I added more RENDER.
      TightCoil TightCoil 4 minutes ago
      No Wonder You Is Called
      Stink Stack
      FNMA
      Konaploinks Konaploinks 4 minutes ago
      I think Luiz should apply at IonQ. They have 30 positions open. Or is he at IBM working on Quantum there? So still no word on the hearing or? There has to be some reason another trial was set so far out. Anyone know why?
      powerbattles powerbattles 4 minutes ago
      Wow! Just breakout $6.00
      ZCAR
      boo boo boo boo 4 minutes ago
      Luigi is a hero in the court of public opinion. CEO images are being posted in a lot of places with "Depose" written on them. Mainstream Media portrays Luigi as a horrible person. Just as they did to trump (a convicted felon). Want facts? Find them on social media, imho.
      UNH
      LowFloatLopes LowFloatLopes 4 minutes ago
      Lfgggg 
      TNXP
      glenn1919 glenn1919 5 minutes ago
      prfx....................https://stockcharts.com/h-sc/ui?s=prfx&p=W&b=5&g=0&id=p86431144783
      PRFX
      boston745 boston745 5 minutes ago
      CDC confirms 1st case of severe bird flu in US
      The patient was hospitalized in Louisiana, the health agency said

      Getting closer to Miami.

      The Centers for Disease Control and Prevention (CDC) has confirmed the first case of severe bird flu in the United States.
      SINT
      Diamondhands45 Diamondhands45 5 minutes ago
      Because I have enough and it's tax selling month. 

      Not hard or figure out unlike you clowns wasting your lives on a stock board when you don't own any stock 
      SPZI
      ttottip ttottip 5 minutes ago
      The factors that pushed this up to $2 remain the same. It's possible to reach the dollar again until tomorrow.
      TNXP
      RKT989 RKT989 5 minutes ago
      not really..why don't you get away from computer and go volunteer somewhere and do some good
      ERHE
      THall THall 5 minutes ago
      That "not long for the world" statement still holds true to this day. DBMM cannot continue to operate at such huge losses. At some point the loan money will run out and they will be forced into bankruptcy liquidation. Not that they have anything of value.

      I just don't understand why y
      DBMM
      EnchantedTitan62 EnchantedTitan62 5 minutes ago
      Built on a $26,000 contract 🤓. Pure foolishness. I got out yesterday, check my posts. Lotta bag holders here, maybe they'll learn. May all your trades be profitable. 🍷
      QUBT
      manibiotech manibiotech 5 minutes ago
      KRISGO

      This is copy and paste from annual report filed by company (10k) earlier this year to SEC
      Not my opinion 
      NWBO
      ORCA ORCA 5 minutes ago
      I AM WAITING TO SEE MY BIDS GET FILLED:)))ITS ONLY AROUND 3 MILLION.HIT THEM AND TAKE THE MONEY.
      VPLM

      Your Recent History

      EU
      ABVX
      Abivax
      LSE
      JREG
      Jpm Grei Ucits
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads